Fortschr Neurol Psychiatr 2017; 85(03): 163-177
DOI: 10.1055/s-0043-103052
Fort- und Weiterbildung
© Georg Thieme Verlag KG Stuttgart · New York

Der komplizierte Alkoholentzug: Grand-Mal-Anfälle, Delir und Wernicke-Enzephalopathie

Alcohol withdrawal and its major complications
Klaus Junghanns
,
Tilman Wetterling
Further Information

Publication History

Publication Date:
20 March 2017 (online)

Abstract

Delirium tremens is one of the most common complications of alcohol withdrawal. It is potentially lethal and therefore should be detected as early as possible and be monitored and treated intensively. The assessment of risk factors with the Luebeck Alcohol-Withdrawal Risk Scale short form (LARS-11) can help to predict the risk of severe withdrawal adequately. As delirium cannot be differentiated from Wernicke-Encephalopathy with sufficient certainty high parenteral doses of Vitamin B1 and Magnesium orally should be given in case of any severe withdrawal symptoms. According to guidelines delirium tremens should be treated with benzodiazepines besides adequate electrolyte and fluid substitution. Haloperidol is often additionally given to better control hallucinations. Delirium tremens usually subsides within 10 days of treatment.

The article gives an overview of alcohol withdrawal with its different facets, its differential diagnoses, and the treatment options.

Während eines Alkoholentzugs kommt es häufig zum Delir oder zu Grand-Mal-Anfällen. Die LARS11-Skala eignet sich dabei zur Abschätzung der Schwere der Entzugssymptomatik. So können rechtzeitig geeignete Therapiemaßnahmen eingeleitet werden.

 
  • Literatur

  • 1 Pabst A. et al. Substanzkonsum und substanzbezogene Störungen in Deutschland im Jahr 2012. Sucht 2013; 59: 321-331
  • 2 Statistisches Bundesamt. Hrsg. Statistisches Jahrbuch 2015. Kapitel 4: Gesundheit. Wiesbaden: Statistisches Bundesamt; 2015
  • 3 Dilling H. Mombour W. Schmidt MH. et al. WHO. , ed Internationale Klassifikation psychischer Störungen: ICD-10 Kapitel V (F) – Klinisch-diagnostische Leitlinien. 10. ed. Göttingen: Hogrefe; 2015
  • 4 Wetterling T. Alkoholfolgeerkrankungen. In: Förstl H. Klinische Neuropsychiatrie. Stuttgart: Thieme; 2000: 354-366
  • 5 Wetterling T. Kanitz RD. Veltrup C. et al. Clinical predictors of alcohol withdrawal delirium. Alcohol Clin Exp Res 1994; 18: 1100-1102
  • 6 Trabert W. Caspari D. Bernhard P. et al. Inappropriate vasopressin secretion in severe alcohol withdrawal. Acta Psychiat Scand 1992; 85: 376-379
  • 7 Wetterling T. Veltrup C. Diagnostik und Therapie von Alkoholproblemen. Berlin: Springer; 1997
  • 8 Shaw JM. Kolesar GS. Sellers EM. et al. Development of optimal treatment tactics for alcohol withdrawal. Assessment and effectiveness of supportive care. J Clin Psychopharmacol 1981; 1: 382-388
  • 9 Banger M. Philipp M. Herth T. et al. Development of a rating scale for quantitative measurement of the alcohol withdrawal syndrome. Eur Arch Psychiatry Clin Neurosci 1992; 241: 241-246
  • 10 Wetterling T. Weber B. Depfenhart M. et al. Development of a rating scale to predict the severity of alcohol withdrawal syndrome. Alcohol 2006; 41: 611-615
  • 11 Driessen M. Lange W. Junghanns K. et al. Proposal of a comprehensive clinical typology of alcohol withdrawal – a cluster analysis approach. Alcohol Alcohol 2005; 40: 308-313
  • 12 Brathen G. Ben-Menachem E. Brodtkorb E. et al. EFNS guideline on the diagnosis and management of alcohol-related seizures: report of an EFNS task force. Eur J Neurol 2005; 12: 575-581
  • 13 Wetterling T. Organische psychische Störungen. Hirnorganische Psychosyndrome. Darmstadt: Steinkopff; 2002
  • 14 Schneider B. Wetterling T. Sucht und Suizidalität. Stuttgart: Kohlhammer; 2016
  • 15 Wetterling T. Schneider B. Alkoholintoxikation und akute Suizidalität. Psychiat Prax 2013; 40: 259-263
  • 16 Soyka M. Alkoholhalluzinose und Eifersuchtswahn. Fortschritte Neurol Psychiatr 2006; 74: 346-352
  • 17 Victor M. Adams RD. Collins GH. The Wernicke-Korsakoff-Syndrome. Philadephia: Davis; 1989
  • 18 Sullivan EV. Pfefferbaum A. Neuroimaging of the Wernicke-Korsakoff syndrome. Alcohol Alcoholism 2009; 44: 155-165
  • 19 Manzo G. De Gennaro A. Cozzolino A. et al. MR imaging findings in alcoholic and nonalcoholic acute Wernicke’s encephalopathy: a review. Biomed Res Int 2014; 2014: 503596
  • 20 Scalzo SJ. Bowden SC. Ambrose ML. et al. Wernicke-Korsakoff syndrome not related to alcohol use: a systematic review. J Neurol Neurosurg Psychiatry 2015; 86: 1362-1368
  • 21 Wijnia JW. Oudman E. Biomarkers of delirium as a clue to diagnosis and pathogenesis of Wernicke-Korsakoff syndrome. Eur J Neurol 2013; 20: 1531-1538
  • 22 Thomson AD. Marshall EJ. The natural history and pathophysiology of Wernicke’s Encephalopathy and Korsakoff’s Psychosis. Alcohol Alcoholism 2006; 41: 151-158
  • 23 Kessels RP. Kopelman MD. Context Memory in Korsakoffʼs syndrome. Neuropsychol Rev 2012; 22: 117-131
  • 24 Kopelman MD. Thomson AD. Guerrini I. et al. The Korsakoff syndrome: clinical aspects, psychology and treatment. Alcohol Alcoholism 2009; 44: 148-154
  • 25 Blansjaar BA. Horjus MC. Nijhuis HG. Prevalence of the Korsakoff syndrome in The Hague, The Netherlands. Acta Psychiat Scand 1987; 75: 604-607
  • 26 David A. Fleminger S. Kopelman M. et al. Lishman’s Organic Psychiatry: A Textbook of Neuropsychiatry. Chichester: Wiley-Blackwell; 2012
  • 27 Berner MM. Habbig S. Härter M. Qualität aktueller Leitlinien zur Diagnostik und Behandlung alkoholbezogener Störungen. Fortschr Neurol Psychiat 2004; 72: 696-704
  • 28 Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF), Deutsche Gesellschaft für Psychiatrie und Psychotherapie, Psychosomatik und Nervenheilkunde (DGPPN), Deutsche Gesellschaft für Suchtforschung und Suchttherapie e.V. (DG-SUCHT). Hrsg. S3-Leitlinie „Screening, Diagnose und Behandlung alkoholbezogener Störungen“. in AWMF-Register Nr. 076-001, AWMF-online: http://www.awmf.org/uploads/tx_szleitlinien/076-001l_S3-Leitlinie_Alkohol_2016-02.pdf (Stand: 6.10.16)
  • 29 Schmidt KJ. Doshi MR. Holzhausen JM. et al. Treatment of severe alcohol withdrawal. Ann Pharmacother 2016; 50: 389-401
  • 30 Ntais C. Pakos E. Kyzas P. et al. Benzodiazepines for alcohol withdrawal. Cochrane Database Syst Rev 2005; DOI: CD005063.
  • 31 Spies CD. Rommelspacher H. Alcohol withdrawal in the surgical patient: prevention and treatment. Anesth Analg 1999; 88: 946-954
  • 32 Wetterling T. Alkoholentzugssyndrom. In: Arolt V. Diefenbacher A. Hrsg. Psychiatrie in der klinischen Medizin. Darmstadt: Steinkopff; 2004: 323-335
  • 33 Saitz R. Mayo-Smith MF. Roberts MS. et al. Individualized treatment for alcohol withdrawal. A randomized double-blind controlled trial. J Am Med Assoc 1994; 272: 519-523
  • 34 Daeppen JB. Gache P. Landry U. et al. Symptom-triggered vs fixed-schedule doses of benzodiazepine for alcohol withdrawal: a randomized treatment trial. Arch Intern Med 2002; 162: 1117-1121
  • 35 Stanley KM. et al. Experience with an adult alcohol withdrawal syndrome practice guideline in internal medicine patients. Pharmacotherapy 2005; 25: 1073-1083
  • 36 Spies CD. Dubisz N. Funk W. et al. Prophylaxis of alcohol withdrawal syndrome in alcohol-dependent patients admitted to the intensive care unit after tumour resection. Br J Anaesth 1995; 75: 734-739
  • 37 Minozzi S. Amato L. Vecchi S. et al. Anticonvulsants for alcohol withdrawal. Cochrane Database Syst Rev 2010; DOI: CD005064.
  • 38 Lum E. Gorman SK. Slavik RS. Valproic acid management of acute alcohol withdrawal. Ann Pharmacother 2006; 40: 441-448
  • 39 Bazire S. Psychotropic Drug Directory. Norwich: Lloyd Reinhold Publications; 2016
  • 40 Flannery AH. Adkins DA. Cook AM. Unpeeling the evidence for the banana bag: evidence-based recommendations for the management of alcohol-associated vitamin and electrolyte deficiencies in the ICU. Crit Care Med 2016; 44: 1545-1552